open access

Vol 25, No 2 (2020)
Published online: 2020-03-01
Submitted: 2019-02-02
Get Citation

Obesity in patients with carcinoma cervix increases the risk of adverse events

Ramaiah Vinay Kumar, Suman Bhasker
DOI: 10.1016/j.rpor.2019.12.024
·
Rep Pract Oncol Radiother 2020;25(2):212-216.

open access

Vol 25, No 2 (2020)
Published online: 2020-03-01
Submitted: 2019-02-02

Abstract

Obesity has become epidemic both in developed and developing countries. Socio-economic (SE) development has resulted in increased prevalence of obesity across all social groups in developing countries that is contrary to the effects of rising SE status on prevalence of obesity in the developed world. Obesity is not only associated with metabolic syndrome, cardiovascular disease, diabetes but is also a risk factor for cancer and is responsible for increased cancer mortality. Published articles have reported higher rates of treatment failure and adverse events (AEs) of anti-cancer therapy in obese patients with carcinoma cervix in comparison to their normal body mass index (BMI) counterparts. Hence, there is a need to elucidate factors that may increase the risk of AEs. Aim of this paper is to discuss the delivery of radiotherapy, concurrent chemotherapy and their effect on AEs in obese patients with carcinoma cervix.

Abstract

Obesity has become epidemic both in developed and developing countries. Socio-economic (SE) development has resulted in increased prevalence of obesity across all social groups in developing countries that is contrary to the effects of rising SE status on prevalence of obesity in the developed world. Obesity is not only associated with metabolic syndrome, cardiovascular disease, diabetes but is also a risk factor for cancer and is responsible for increased cancer mortality. Published articles have reported higher rates of treatment failure and adverse events (AEs) of anti-cancer therapy in obese patients with carcinoma cervix in comparison to their normal body mass index (BMI) counterparts. Hence, there is a need to elucidate factors that may increase the risk of AEs. Aim of this paper is to discuss the delivery of radiotherapy, concurrent chemotherapy and their effect on AEs in obese patients with carcinoma cervix.

Get Citation

Keywords

Carcinoma cervix; Obesity; Adverse events (AEs); Developing countries; Chemo-radiotherapy

About this article
Title

Obesity in patients with carcinoma cervix increases the risk of adverse events

Journal

Reports of Practical Oncology and Radiotherapy

Issue

Vol 25, No 2 (2020)

Pages

212-216

Published online

2020-03-01

DOI

10.1016/j.rpor.2019.12.024

Bibliographic record

Rep Pract Oncol Radiother 2020;25(2):212-216.

Keywords

Carcinoma cervix
Obesity
Adverse events (AEs)
Developing countries
Chemo-radiotherapy

Authors

Ramaiah Vinay Kumar
Suman Bhasker

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk, Poland
tel.:+48 58 320 94 94, fax:+48 58 320 94 60, e-mail: journals@viamedica.pl